Drug class
Selective beta-2 adrenergic receptor agonist; sympathomimetic bronchodilator
Mechanism of action
Stimulates beta-2 adrenergic receptors in bronchial smooth muscle, activating adenylate cyclase and increasing intracellular cyclic AMP, which relaxes airway smooth muscle. At higher exposures it can produce systemic beta-adrenergic effects.
General use cases
- Bronchodilator use for reversible airway obstruction in jurisdictions where a clenbuterol medicinal product is authorised; not approved for human medical use in some countries, including the United States. It is prohibited in sport under anti-doping rules.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
